United Therapeutics chair discloses 9,500-share sale
Martine A. Rothblatt, chair of United Therapeutics, reported selling 9,500 shares under a 10b5-1 plan. The Form 4 also shows an exercise of 9,500 shares.
Martine A. Rothblatt, chair of United Therapeutics, reported selling 9,500 shares under a 10b5-1 plan. The Form 4 also shows an exercise of 9,500 shares.